Total Payments
$149,377
2024 Payments
$31,787
Companies
47
Transactions
1,346
Medicare Patients
12,127
Medicare Billing
$818,292
Payment Breakdown by Category
Other$109,100 (73.0%)
Food & Beverage$24,416 (16.3%)
Consulting$12,750 (8.5%)
Travel$2,695 (1.8%)
Education$232.32 (0.2%)
Gifts$182.95 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $109,100 | 36 | 73.0% |
| Food and Beverage | $24,416 | 1,279 | 16.3% |
| Consulting Fee | $12,750 | 6 | 8.5% |
| Travel and Lodging | $2,695 | 13 | 1.8% |
| Education | $232.32 | 11 | 0.2% |
| Gift | $182.95 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $70,620 | 205 | $0 (2022) |
| ABBVIE INC. | $60,329 | 269 | $0 (2024) |
| Galderma Laboratories, L.P. | $4,361 | 142 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,519 | 86 | $0 (2024) |
| GENZYME CORPORATION | $1,236 | 60 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $898.73 | 20 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $856.49 | 36 | $0 (2024) |
| Lilly USA, LLC | $783.13 | 37 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $768.95 | 25 | $0 (2024) |
| LEO Pharma Inc. | $768.02 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31,787 | 187 | ABBVIE INC. ($29,119) |
| 2023 | $31,624 | 185 | ABBVIE INC. ($29,637) |
| 2022 | $20,918 | 163 | Allergan, Inc. ($18,186) |
| 2021 | $18,697 | 145 | Allergan, Inc. ($16,709) |
| 2020 | $4,376 | 115 | Galderma Laboratories, L.P. ($2,502) |
| 2019 | $16,597 | 170 | Allergan Inc. ($14,503) |
| 2018 | $7,688 | 186 | Allergan Inc. ($5,105) |
| 2017 | $17,691 | 195 | Allergan Inc. ($15,422) |
All Payment Transactions
1,346 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $112.28 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Immunology | ||||||
| 11/13/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $56.18 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $41.84 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $31.88 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.56 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/17/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $39.61 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/17/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $13.09 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,785 | 4,381 | $609,932 | $187,115 |
| 2022 | 23 | 3,575 | 5,960 | $772,369 | $241,097 |
| 2021 | 21 | 3,205 | 5,176 | $676,757 | $224,194 |
| 2020 | 21 | 2,562 | 4,491 | $523,149 | $165,886 |
Total Patients
12,127
Total Services
20,008
Medicare Billing
$818,292
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 493 | 585 | $138,060 | $46,158 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 541 | 659 | $122,574 | $37,625 | 30.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 315 | 357 | $77,469 | $19,047 | 24.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 488 | 603 | $82,008 | $18,641 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 181 | $45,793 | $15,298 | 33.4% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 21 | 31 | $24,233 | $9,316 | 38.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 330 | 1,432 | $20,048 | $7,669 | 38.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 79 | 79 | $18,012 | $6,067 | 33.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 28 | 38 | $13,034 | $4,982 | 38.2% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 24 | 36 | $10,961 | $3,699 | 33.7% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 32 | 38 | $10,488 | $3,465 | 33.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 60 | 86 | $9,460 | $3,461 | 36.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 21 | 23 | $7,061 | $2,826 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $7,820 | $2,355 | 30.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 69 | 70 | $8,050 | $2,141 | 26.6% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 16 | 17 | $4,318 | $1,483 | 34.4% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 13 | $3,991 | $1,476 | 37.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 16 | 18 | $2,088 | $556.68 | 26.7% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 13 | $2,665 | $550.86 | 20.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 13 | $611.00 | $241.98 | 39.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 25 | 66 | $1,188 | $56.01 | 4.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 582 | 690 | $162,840 | $56,016 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 652 | 839 | $156,054 | $49,381 | 31.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 399 | 480 | $104,160 | $26,793 | 25.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 608 | 757 | $102,952 | $23,634 | 23.0% |
About Mary Fleischli, M. D
Mary Fleischli, M. D is a Dermatology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245228063.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mary Fleischli, M. D has received a total of $149,377 in payments from pharmaceutical and medical device companies, with $31,787 received in 2024. These payments were reported across 1,346 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($109,100).
As a Medicare-enrolled provider, Fleischli has provided services to 12,127 Medicare beneficiaries, totaling 20,008 services with total Medicare billing of $818,292. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Dallas, TX
- Active Since 10/06/2005
- Last Updated 07/30/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1245228063
Products in Payments
- BOTOX (Biological) $36,098
- BOTOX COSMETIC (Biological) $12,807
- DUPIXENT (Biological) $1,357
- SKYRIZI (Biological) $1,334
- COSENTYX (Biological) $1,072
- DAXXIFY (Drug) $715.53
- TALTZ (Drug) $661.29
- RINVOQ (Biological) $635.87
- OPZELURA (Drug) $566.41
- EUCRISA (Drug) $562.54
- Impoyz (Drug) $508.29
- Humira (Biological) $477.99
- Otezla (Drug) $450.06
- DORYX (Drug) $447.27
- Winlevi (Drug) $412.97
- ADBRY (Biological) $402.25
- DUPIXENT (Drug) $400.18
- COSENTYX (Drug) $360.21
- TREMFYA (Drug) $321.09
- ENSTILAR (Drug) $288.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Dallas
Dr. Jennifer Cather, M.d, M.D
Dermatology — Payments: $1.8M
Dermatology $1.8M
Dr. Joseph Merola, M.d., M.m.sc, M.D., M.M.SC
Dermatology — Payments: $1.7M
Dermatology $1.7M
Dr. Martin Menter, Md, MD
Dermatology — Payments: $1.1M
Dermatology $1.1M
Dr. So Yeon Paek, M.d, M.D
Dermatology — Payments: $637,453
Dermatology $637,453
Dr. William Abramovits, M.d, M.D
Dermatology — Payments: $634,225
Dermatology $634,225
Dr. Ross Radusky, M.d, M.D
Dermatology — Payments: $598,043
Dermatology $598,043